financetom
Business
financetom
/
Business
/
FCS playoffs offered plan to go private
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FCS playoffs offered plan to go private
Sep 25, 2025 2:12 PM

A proposal to the Football Championship Subdivision (FCS) commissioners could eventually turn over management of the NCAA's Division 1 FCS playoffs to a private equity firm, Front Office Sports learned on Thursday.

Sequence Equity, a private equity firm, recently presented a plan to transfer the management of the NCAA's Division I FCS playoffs to a private entity. Under the proposal, FCS conferences would hold a majority stake in the playoffs, with the firm in a minority position providing capital in investment to boost playoff revenue.

Per Front Office Sports, the NCAA has not responded to a request for comment, nor have multiple FCS leagues. The news of the proposal was first reported by Hero Sports.

If approved, the proposal would have a similar look to the College Football Playoff, an LLC owned by Football Bowl Subdivision conferences and Notre Dame that operates outside the NCAA and holds a six-year, $7.8 billion media rights package. FBS schools receive hundreds of millions of dollars from the LLC.

While the FCS wouldn't come close to matching the FBS' media rights, Sequence Entity -- which describes itself as "a multi-strategy investment platform based in Los Angeles, investing in sports, media, entertainment, technology, and infrastructure" -- believes FCS schools are missing out on media-rights dollars under their current setup.

The 24-team postseason bracket in the FCS, which includes 13 leagues and more than 100 schools with football programs, is owned and operated by the NCAA. The NCAA also owns the media rights for the championship game, agreeing to a deal last year as part of a bundle with several other championships airing on ESPN. The network forks over approximately $115 million each year for those rights.

--Field Level Media

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved